Revolution Medicines, Inc. vs Johnson & Johnson
RVMD vs JNJ — side-by-side comparison from reported financials. RVMD leads 2, JNJ leads 4 of 6 comparable metrics.
Revolution Medicines, Inc.
RVMD · Healthcare
$189.76+0.87%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | RVMD | JNJ |
|---|---|---|
| Price | $189.76 | $261.79 |
| Market cap | $40.7B | $631B |
| Revenue (TTM) | $0 | $97.9B |
| Revenue growth | — | +5.6% |
| Net margin | — | 21.5% |
| Free cash flow | -$2.65B | $22.2B |
| Net cash (debt) | $2.75B | ($27.8B) |
| 1-year price return | +298.5% | +37.0% |
| P/E | — | 29.9 |
| P/E vs own history (cheap-side %) | — | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -54% | 26% |
| CV checks passed | 3 of 8 | 10 of 8 |
| Employees | 883 | 140,800 |
Full résumé-style profiles: RVMD CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.